IDSA Updates COVID Guidelines for Antibodies, Antivirals, Others IDSA Updates COVID Guidelines for Antibodies, Antivirals, Others
Infectious disease experts critically review evidence for use of bamlanivimab, address new data on remdesivir and tocilizumab, and comment on new findings for the Oxford University COVID-19 vaccine.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
More News: Actemra | COVID-19 | Drugs & Pharmacology | Infectious Diseases | Oxford University | Vaccines